Citi & Lazard Capital Jump on Bandwagon - Upgrade Human Genome Sciences (HGSI)
Tweet Send to a Friend
Citi upgrades Human Genome Sciences (Nasdaq: HGSI) from Hold to Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
